Syra Health Announces Delisting from Nasdaq Capital Market
Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to enhancing health through innovative technology solutions, has informed the Nasdaq Stock Market of its intention to voluntarily delist its common stock from the Nasdaq Capital Market. This decision is a part of the company’s strategy for optimizing its operations.
Reasons Behind the Delisting Decision
The management team of Syra Health has conducted a detailed assessment and concluded that delisting is necessary. This strategic pause aims to refocus efforts on enhancing the company’s fundamental operations while concurrently reducing costs associated with maintaining a Nasdaq listing. Management believes that this initiative will allow them to better streamline operations, improve overall financial health, and foster sustainable growth in the long term.
Anticipated Timeline for Delisting
The company plans to file a Form 25, Notification of Removal of Listing and/or Registration Under Section 12(b) with the Securities and Exchange Commission, reflecting this decision. The expected timeline for the delisting includes taking effect approximately ten days post-filing, with the last trading day on the Nasdaq projected to be shortly after. This proactive approach is aimed at ensuring a smoother transition while maintaining consistent communication with shareholders.
Future Trading and Market Presence
Syra Health anticipates its common stock will be quoted on the OTC market following the delisting. The intention is to continue sharing relevant information with shareholders and to take measures that will support the ongoing trading of its common stock. Nevertheless, there is no assurance that any broker will continue to facilitate trades in the company’s shares or that there will be a continuous market for them on the OTC.
Company’s Commitment to Shareholders
Syra Health remains committed to its shareholders. Communication efforts will persist to ensure that shareholders are updated on developments. While plans for relisting on a national securities exchange might be in consideration for the future, current efforts will focus on maintaining the company’s presence and liquidity in the market.
About Syra Health
Syra Health is a leader in healthcare technology, focusing on pivotal issues such as mental health, population health, and workforce solutions. The company’s groundbreaking technology and innovative services prioritize accessibility, prevention, and affordability in healthcare. Syra Health's ongoing mission is to advance effective healthcare solutions that impact lives nationwide and beyond.
Frequently Asked Questions
Why is Syra Health delisting from Nasdaq?
Syra Health is delisting to focus on its core operations and reduce costs associated with maintaining a Nasdaq listing.
When is the last trading day on Nasdaq for Syra Health?
The expected last trading day on Nasdaq is projected to be shortly after the filing of the Form 25.
What will happen to Syra Health's stock after delisting?
The common stock is expected to be quoted on the OTC market, allowing for continued trading opportunities.
How will Syra Health communicate with shareholders?
Syra Health is committed to keeping shareholders informed about developments and actions taken post-delisting.
What is Syra Health's mission?
Syra Health's mission is to enhance healthcare through innovative technology solutions that improve accessibility and affordability.
